Metabolism and health effects of phyto-estrogens

References

• Adlercreutz, H. (1998). Epidemiology of phytoestrogens. Baillière's Clin. Endoc. Metab. 12:605–623.
   PubMed Web of Science ®Google Scholar
• Aedin, Cassidy, Paola, Albertazzi, Inge, Lise Nielsen, Wendy, Hall, et al. (2006). Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc. Nutr. Soc. 65:76–92.
   PubMed Web of Science ®Google Scholar
• Alcantara, E. H., Shin, M.-Y., Sohn, H.-Y., Park, Y.-M., Kim, T., Lim, J.-H., et al. (2011). Diosgenin stimulates osteogenic activity by increasing bone matrix protein synthesis and bone-specific transcription factor Runx2 in osteoblastic MC3T3-E1 cells. J. Nutr. Biochem. 22:1055–1063.
   PubMed Web of Science ®Google Scholar
• Alekel, D. L., Van Loan, M. D., Koehler, K. J., Hanson, L. N., Stewart, J. W., Hanson, K. B., et al. (2010). The soy isoflavones for reducing bone loss (SIRBL) study: A 3-y randomized controlled trial in postmenopausal women. Am. J. Clin. Nutr. 91:218–230.
   PubMed Web of Science ®Google Scholar
• Anderson, J. W., Johnstone, B. M. and Cook-Newell, M. E. (1995). Meta-analysis of the effects of soy protein intake on serum lipids. New Engl. J. Med. 333:276–282.
   PubMed Web of Science ®Google Scholar
• Anderson, K. M., Odell, P. M., Wilson, P. W. and Kannel, W. B. (1991). Cardiovascular disease risk profiles. Am. Heart J. 121:293–298.
   PubMed Web of Science ®Google Scholar
• Anderson, L. N., Cotterchio, M., Boucher, B. A. and Kreiger, N. (2013). Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women. Int. J. Cancer. 132:1683–1692.
   PubMed Web of Science ®Google Scholar
• Atkinson, C., Compston, J. E., Day, N. E., Dowsett, M. and Bingham, S. A. (2004). The effects of phytoestrogen isoflavones on bone density in women: A double-blind, randomized, placebo-controlled tria1-3. Am. J. Clin. Nutr. 79:326–333.
   PubMed Web of Science ®Google Scholar
• Atkinson, C., Frankenfeld, C. L. and Lampe, J. W. (2005). Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health. Exp. Biol. Med. 230:155–170.
   PubMed Web of Science ®Google Scholar
• Atkinson, C., Warren, R., Sala, E., Dowsett, M., Dunning, A. M., Healey, C. S., et al. (2004). Red-clover-derived isoflavones and mammographic breast density: A double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Breast Cancer Res. 6:R170–R179.
   PubMed Web of Science ®Google Scholar
• Atteritano, M., Marini, H., Minutoli, L., Polito, F., Bitto, A., Altavilla, D., et al. (2007). Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study. J. Clin. Endoc. Metab. 92:3068–3075.
   PubMed Web of Science ®Google Scholar
• Axelson, M., Sjövall, J., Gustafsson, B. E., and Setchell, K. D. R. (1982). Origin of lignans in mammals and identification of a precursor from plants. Nature. 298(5875):659–660.
   Google Scholar
• Bandyopadhyay, S., Lion, J.-M., Mentaverri, R., Ricupero, D. A., Kamel, S., Romero, J. R., et al. (2006). Attenuation of osteoclastogenesis and osteoclast function by apigenin. Biochem. Pharmacol. 72:184–197.
   PubMed Web of Science ®Google Scholar
• Barnes, S. (2003). Phyto-oestrogens and osteoporosis: what is a safe dose?[J]. Brit. J. Nutr. 89(S1):S101–S108.
   PubMedGoogle Scholar
• Bateman, H. L. and Patisaul, H. B. (2008). Disrupted female reproductive physiology following neonatal exposure to phytoestrogens or estrogen specific ligands is associated with decreased GnRH activation and kisspeptin fiber density in the hypothalamus. Neurotoxicology. 29:988–997.
   PubMed Web of Science ®Google Scholar
• Beavers, D. P., Beavers, K. M., Miller, M., Stamey, J. and Messina, M. J. (2012). Exposure to isoflavone-containing soy products and endothelial function: A Bayesian meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis. 22:182–191.
   PubMed Web of Science ®Google Scholar
• Beral, V. (2007). Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet. 369:1703–1710.
   PubMed Web of Science ®Google Scholar
• Bingham, S., Atkinson, C., Liggins, J., Bluck, L. and Coward, A. (1998). Phyto-oestrogens: Where are we now? Brit. J. Nutr. 79:393–406.
   PubMed Web of Science ®Google Scholar
• Bolaños, R., Del Castillo, A. and Francia, J. (2010). Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis[J]. Menopause. 17(3):660–666.
   PubMedGoogle Scholar
• Boucher, B. A., Cotterchio, M., Anderson, L. N., Kreiger, N., Kirsh, V. A. and Thompson, L. U. (2013). Use of isoflavone supplements is associated with reduced postmenopausal breast cancer risk. Int. J. Cancer. 132:1439–1450.
   PubMed Web of Science ®Google Scholar
• Branca, F. (2003). Dietary phyto-oestrogens and bone health. Proc. Nutr. Soc. 62:877–887.
   PubMed Web of Science ®Google Scholar
• Briese, V. (2000). Phytoöstrogene [J]. Der Gynäkologe. 33(1):28–35.
   Google Scholar
• Brink, E, Coxam, V, Robins, S, Wahala, K, Cassidy, A and Branca, F. (2008). Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. Am. J. Clin. Nutr. 87:761–770.
   PubMed Web of Science ®Google Scholar
• Brössner, C., Petritsch, K., Fink, K., et al. (2006). Prostatic phyto-oestrogen tissue levels in different Austrian regions[J]. Urol. Int. 76(4):327–331.
   PubMedGoogle Scholar
• Buteau-Lozano, H., Velasco, G., Cristofari, M., Balaguer, P. and Perrot-Applanat, M. (2008). Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism. J. Endoc. 196:399–412.
   PubMed Web of Science ®Google Scholar
• Caan, B. J., Natarajan, L., Parker, B., Gold, E. B., Thomson, C., Newman, V., et al. (2011). Soy food consumption and breast cancer prognosis. Cancer Epidem. Biomar. Prev. 20:854–858.
   PubMed Web of Science ®Google Scholar
• Campbell, S. C., Khalil, D. A., Payton, M. E. and Arjmandi, B. H. (2010). One-year soy protein supplementation does not improve lipid profile in postmenopausal women. Menopause. 17:587–593.
   PubMed Web of Science ®Google Scholar
• Cano, A., Dapia, S., Noguera, I., Pineda, B., Hermenegildo, C., Del, Val R., et al. (2008). Comparative effects of 17β-estradiol, raloxifene and genistein on bone 3D microarchitecture and volumetric bone mineral density in the ovariectomized mice. Osteoporos. Int. 19:793–800.
   PubMed Web of Science ®Google Scholar
• Cassidy, A., Albertazzi, P., Nielsen, I. L., et al. (2006). Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women[J]. Proc. Nutr. Soc. 65(01):76–92.
   PubMedGoogle Scholar
• Castoria, G., Migliaccio, A., Bilancio, A., Di Domenico, M., de Falco, A., Lombardi, M., et al. (2001). PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 20:6050–6059.
   PubMed Web of Science ®Google Scholar
• Chen, C. L., Weiss, N. S., Newcomb, P., et al. (2002). Hormone replacement therapy in relation to breast cancer[J]. JAMA. 287(6):734–741.
   PubMed Web of Science ®Google Scholar
• Chen, J., Hui, E., Ip, T. and Thompson, L. U. (2004). Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (MCF-7) in nude mice. Clin. Cancer Res. 10:7703–7711.
   PubMed Web of Science ®Google Scholar
• Chen, J., Lin, H. and Hu, M. (2005). Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model. Cancer Chemoth. Pharmaco. 55:159–169.
   PubMed Web of Science ®Google Scholar
• Chen, Y.-M., Ho, S. C., Lam, S. S..H., Ho, S. S. S. and Woo, J. L. F. (2004). Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: A double-blind, randomized, controlled trial. Menopause. 11:246–254.
   PubMed Web of Science ®Google Scholar
• Chen, J., and Liu, X. (2014). Effects on blood fat and bone density of postmenopausal women fed by soy protein with isoflavone. Zhonghua yi Xue za Zhi. 94(3):215–217.
   PubMedGoogle Scholar
• Cheng, G., Wilczek, B., Warner, M., Gustafsson, J. Å., and Landgren, B. M. (2007). Isoflavone treatment for acute menopausal symptoms. Menopause. 14(3):468–473.
   PubMed Web of Science ®Google Scholar
• Clavel, T., Henderson, G., Engst, W., Doré, J. and Blaut, M. (2006). Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside. FEMS Microbiol. Ecol. 55:471–478.
   PubMed Web of Science ®Google Scholar
• Clifton-Bligh, P. B., Nery, M. L., Clifton-Bligh, R. J., Visvalingam, S., Fulcher, G. R., Byth, K., and Baber, R. (2015). Red clover isoflavones enriched with formononetin lower serum LDL cholesterol – a randomized, double-blind, placebo-controlled study. Eur. J. Clin. Nutr. 69(1):134–142.
   PubMed Web of Science ®Google Scholar
• Cohen, L., Zhao, Z., Pittman, B. and Scimeca, J. (2000). Effect of intact and isoflavone-depleted soy protein on NMU-induced rat mammary tumorigenesis. Carcinogenesis. 21:929–935.
   PubMed Web of Science ®Google Scholar
• Colacurci, N., Chiantera, A., Fornaro, F., de Novellis, V., Manzella, D., Arciello, A., et al. (2005). Effects of soy isoflavones on endothelial function in healthy postmenopausal women. Menopause. 12:299–307.
   PubMed Web of Science ®Google Scholar
• Cole, Z, Dennison, E. and Cooper, C. (2008). Update on the treatment of post-menopausal osteoporosis. Brit. Med. Bull. 86:129–143.
   PubMed Web of Science ®Google Scholar
• Collins-Burow, B. M., Antoon, J. W., Frigo, D. E., Elliott, S., Weldon, C. B., Boue, S. M., et al. (2012). Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha. J. Steroid Biochem. Mol. Biol. 132:186–193.
   PubMed Web of Science ®Google Scholar
• Come, S. E., Buzdar, A. U., Arteaga, C. L., Brodie, A. M., Davidson, N. E., Dowsett, M., et al. (2003). Second international conference on recent advances and future directions in endocrine manipulation of breast cancer summary consensus statement. Clin. Cancer Res. 9:443s–446s.
   PubMed Web of Science ®Google Scholar
• Constantinou, A. I., Lantvit, D., Hawthorne, M., Xu, X., van Breemen, R. B. and Pezzuto, J. M. (2001). Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague–Dawley rats. Nutr. Cancer. 41:75–81.
   PubMed Web of Science ®Google Scholar
• Cotterchio, M, Boucher, B. A., Kreiger, N., Mills, C. A. and Thompson, L. U. (2008). Dietary phytoestrogen intake – lignans and isoflavones – and breast cancer risk (Canada). Cancer Causes Contr. 19:259–272.
   PubMed Web of Science ®Google Scholar
• Crespy, V., Morand, C., Manach, C., Besson, C., Demigne, C. and Remesy, C. (1999). Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. Am. J. Physiol. Gastrointest. Liver Physiol. 277(1):G120–G126.
   Web of Science ®Google Scholar
• Crisafulli, A., Marini, H., Bitto, A, Altavilla, D., Squadrito, G., Romeo, A., et al. (2004). Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT and placebo-controlled study. Menopause. 11:400–404.
   PubMed Web of Science ®Google Scholar
• Davis, D. D., Díaz-Cruz, E. S., Landini, S., Kim, Y.-W. and Brueggemeier, R. W. (2008). Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cells. J. Steroid Biochem. Mol. Biol. 108:23–31.
   PubMed Web of Science ®Google Scholar
• Davis, D. D., Díaz-Cruz, E. S., Landini, S., Kim, Y.-W. and Brueggemeier, R. W. (2008). Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cells. J. Steroid Biochem. Mol. Biol. 108:23–31.
   PubMed Web of Science ®Google Scholar
• Day, A. J., DuPont, M. S., Ridley, S., Rhodes, M., Rhodes, M. J., Morgan, M. R., et al. (1998). Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity. FEBS Lett. 436:71–75.
   PubMed Web of Science ®Google Scholar
• Day, A. J., Cañada, F. J., Díaz, J. C., Kroon, P. A., Mclauchlan, R., Faulds et al. (2000). Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett. 468(2):166–170.
   PubMed Web of Science ®Google Scholar
• de Boer, V. C., Dihal, A. A., van der Woude, H., Arts, I. C., Wolffram, S., Alink, G. M., et al. (2005). Tissue distribution of quercetin in rats and pigs. J. Nutr. 135:1718–1725.
   PubMed Web of Science ®Google Scholar
• de Lemos, M. L. (2001). Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann. Pharmacother. 35:1118–1121.
   PubMed Web of Science ®Google Scholar
• Decroos, K., Vanhemmens, S., Cattoir, S., Boon, N. and Verstraete, W. (2005). Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Arch. Microbiol. 183:45–55.
   PubMed Web of Science ®Google Scholar
• D'Mello, J. F. (1997). Handbook of Plant and Fungal Toxicants. CRC Press, Boca Raton, Florida, pp. 117–137.
   Google Scholar
• Donovan, J. L., Manach, C., Faulks, R. M., and Kroon, P. A. (2006). Absorption and metabolism of dietary plant secondary metabolites. In: Plant Secondary Metabolites: Occurrence, Structure and Role in the Human Diet, pp. 303–351. A. Crozier., M. N. Clifford and H. Ashihara., eds., Blackwell Publishing Ltd, Oxford, UK.
   Google Scholar
• Engel, N., Lisec, J., Piechulla, B., and Nebe, B. (2012). Metabolic profiling reveals sphingosine-1-phosphate kinase 2 and lyase as key targets of (phyto-) estrogen action in the breast cancer cell line mcf-7 and not in mcf-12a. Plos One. 7(10):576–576.
   Google Scholar
• Farina, H. G., Pomies, M., Alonso, D. F. and Gomez, D. E. (2006). Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol. Rep. 16:885–891.
   PubMed Web of Science ®Google Scholar
• Faure, C., Linossier, M.-T., Malaval, L., Lafage-Proust, M.-H., Peyroche, S., Vico, L, et al. (2008). Mechanical signals modulated vascular endothelial growth factor-A (VEGF-A) alternative splicing in osteoblastic cells through actin polymerisation. Bone. 42:1092–1101.
   PubMed Web of Science ®Google Scholar
• Feinleib, M., Garrison, R., Fabsitz, R., Christian, J., Hrubec, Z., Borhani, N., et al. (1977). The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. Am. J. Epidemiol. 106:284–295.
   PubMed Web of Science ®Google Scholar
• Ferenc, P., Solár, P., Kleban, J., Mikeš, J. and Fedoročko, P. (2010). Down-regulation of Bcl-2 and Akt induced by combination of photoactivated hypericin and genistein in human breast cancer cells. J. Photochem. Photobio. B. 98:25–34.
   PubMed Web of Science ®Google Scholar
• Filipović, B., Šošić-Jurjević, B., Ajdžanović, V., Brkić, D., Manojlović-Stojanoski, M., Milošević, V., et al. (2010). Daidzein administration positively affects thyroid C cells and bone structure in orchidectomized middle-aged rats. Osteoporos. Int. 21:1609–1616.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. (1999). Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule. Fed Regist. 64:57700–57733.
   Google Scholar
• Foster, W. G., Younglai, E. V., Boutross-Tadross, O., Hughes, C. L. and Wade, M. G. (2004). Mammary gland morphology in Sprague-Dawley rats following treatment with an organochlorine mixture in utero and neonatal genistein. Toxicol. Sci. 77:91–100.
   PubMed Web of Science ®Google Scholar
• Foti, P., Erba, D., Spadafranca, A., Ciappellano, S., Bresciani, J. and Testolin, G. (2006). Daidzein is absorbed by passive transport in isolated small intestine of rats. Nutr. Res. 26:284–288.
   Web of Science ®Google Scholar
• Frankenfeld, C. L., McTiernan, A., Thomas, W. K., LaCroix, K., McVarish, L., Holt, V. L., et al. (2006). Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes. Maturitas. 53:315–324.
   PubMed Web of Science ®Google Scholar
• Frasor, J., Stossi, F., Danes, J. M., Komm, B., Lyttle, C. R. and Katzenellenbogen, B. S. (2004). Selective estrogen receptor modulators discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res. 64:1522–1533.
   PubMed Web of Science ®Google Scholar
• French, M. R., Thompson, L. U. and Hawker, G. A. (2007). Validation of a phytoestrogen food frequency questionnaire with urinary concentrations of isoflavones and lignan metabolites in premenopausal women. J. Am. Coll. Nutr. 26:76–82.
   PubMed Web of Science ®Google Scholar
• Fujioka, M., Uehara, M., Wu, J., Adlercreutz, H., Suzuki, K. and Kanazawa, K., et al. (2004). Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice. J. Nutr. 134:2623–2627.
   PubMed Web of Science ®Google Scholar
• Gallo, D., Giacomelli, S., Cantelmo, F., Zannoni, G. F., Ferrandina, G., Fruscella, E., et al. (2001). Chemoprevention of DMBA-induced mammary cancer in rats by dietary soy. Breast Cancer Res. Treat. 69:153–164.
   PubMed Web of Science ®Google Scholar
• Gao, Y. H. and Yamaguchi, M. (1999). Inhibitory effect of genistein on osteoclast-like cell formation in mouse marrow cultures. Biochem. Pharmacol. 58:767–772.
   PubMed Web of Science ®Google Scholar
• Gee, J. M., DuPont, M. S., Day, A. J., Plumb, G. W., Williamson, G. and Johnson, I. T. (2000). Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. J. Nutr. 130:2765–2771.
   PubMed Web of Science ®Google Scholar
• Gee, J. M., DuPont, M. S., Rhodes, M. J. C. and Johnson, I. T. (1998). Quercetin glucosides interact with the intestinal glucose transport pathway. Free Radical Biol. Med. 25:19–25.
   PubMed Web of Science ®Google Scholar
• Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., et al. (2013). Executive summary: Heart disease and stroke statistics – 2013 update. A report from the American Heart Association. Circulation. 127:143–152.
   PubMed Web of Science ®Google Scholar
• González-Granillo, M, Steffensen, K., Granados, O., Torres, N., Korach-André, M., Ortíz, V., et al. (2012). Soy protein isoflavones differentially regulate liver X receptor isoforms to modulate lipid metabolism and cholesterol transport in the liver and intestine in mice. Diabetologia. 55:2469–2478.
   PubMed Web of Science ®Google Scholar
• Goodman, M. T., Shvetsov, Y. B., Wilkens, L. R., Franke, A. A., Le Marchand, L., Kakazu, K. K., et al. (2009). Urinary phytoestrogen excretion and postmenopausal breast cancer risk: The multi-ethnic cohort study. Cancer Prev. Res. 2:887–894.
   PubMed Web of Science ®Google Scholar
• Goodman-Gruen, D and Kritz-Silverstein, D. (2001). Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J. Nutr. 131:1202–1206.
   PubMed Web of Science ®Google Scholar
• Gossell-Williams, M., Hyde, C., Hunter, T., Simms-Stewart, D., Fletcher, H., McGrowder, D., and Walters, C. A. (2011). Improvement in HDL cholesterol in postmenopausal women supplemented with pumpkin seed oil: pilot study. Climacteric. 14(5):558–564.
   PubMed Web of Science ®Google Scholar
• Gottstein, N., Ewins, B. A., Eccleston, C., Hubbard, G. P., Kavanagh, I. C., Minihane, A. M., et al. (2003). Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function. Brit. J. Nutr. 89:607–615.
   PubMed Web of Science ®Google Scholar
• Guengerich, F. P. (2003). Cytochromes P450, drugs, and diseases. Mol. Interv. 3(4):194.
   PubMedGoogle Scholar
• Guha, N., Kwan, M. L., Quesenberry Jr, C. P., Weltzien, E. K., Castillo, A. L., and Caan, B. J. (2009). Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: The life after cancer epidemiology study. Breast Cancer Res. Treat. 118(2):395–405.
   PubMed Web of Science ®Google Scholar
• Guo, A. J., Choi, R. C., Cheung, A. W., Chen, V. P., Xu, S. L., Dong, T. T., et al. (2011). Baicalin, a flavone, induces the differentiation of cultured osteoblasts an action via the Wnt/β-catenin signaling pathway. J. Biol. Chem. 286:27882–27893.
   PubMed Web of Science ®Google Scholar
• Hall, W. L., Vafeiadou, K., Hallund, J., Bugel, S., Reimann, M., Koebnick, C., et al. (2006). Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: Interactions with genotype and equol production. Am. J. Clin. Nutr. 83:592–600.
   PubMed Web of Science ®Google Scholar
• Hertrampf, T., Schleipen, B., Offermanns, C., Velders, M., Laudenbach, U. and Diel, P. (2009). Comparison of the bone protective effects of an isoflavone-rich diet with dietary and subcutaneous administrations of genistein in ovariectomized rats. Toxicol. Lett. 184:198–203.
   PubMed Web of Science ®Google Scholar
• Ho, S. C., Chen, Y.-M., Ho, S. S. and Woo, J. L. (2007). Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: A double-blind, randomized, placebo-controlled trial. Menopause. 14:905–912.
   PubMed Web of Science ®Google Scholar
• Horn-Ross, P. L., John, E. M., Lee, M., Stewart, S. L., Koo, J., Sakoda, L. C., et al. (2001). Phytoestrogen consumption and breast cancer risk in a multiethnic population the Bay Area Breast Cancer Study. Am. J. Epidemiol. 154:434–441.
   PubMed Web of Science ®Google Scholar
• Hsieh, C. Y, Santell, R. C., Haslam, S. Z. and Helferich, W. G. (1998). Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 58:3833–3838.
   PubMed Web of Science ®Google Scholar
• Hu, M., Krausz, K., Chen, J., Ge, X., Li, J, Gelboin, H. L., et al. (2003). Identification of CYP1A2 as the main isoform for the phase I hydroxylated metabolism of genistein and a prodrug converting enzyme of methylated isoflavones. Drug Metab. Dispos. 31:924–931.
   PubMed Web of Science ®Google Scholar
• Huh, J.-E., Nam, D.-W., Baek, Y.-H., Kang, J. W., Park, D.-S., Choi, D.-Y., et al. (2011). Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways. Int. Immunopharm. 11:46–54.
   PubMed Web of Science ®Google Scholar
• Hur, H. G. and Rafii, F. (2006). Biotransformation of the isoflavonoids biochanin A, formononetin, and glycitein by Eubacterium limosum. FEMS Microbiol. Lett. 192:21–25.
   Google Scholar
• Hutchins, A. M., Martini, M. C., Olson, B. A., Thomas, W., and Slavin, J. L. (2000). Flaxseed influences urinary lignan excretion in a dose-dependent manner in postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 9:1113–1118.
   PubMed Web of Science ®Google Scholar
• Iwasaki, M., Inoue, M., Otani, T., Sasazuki, S., Kurahashi, N, Miura, T., et al. (2008). Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: A nested case-control study from the Japan Public Health Center-based prospective study group. J. Clin. Oncol. 26:1677–1683.
   PubMed Web of Science ®Google Scholar
• Jaganath, I. B. and Crozier, A. L. A. N. (2010). Dietary flavonoids and phenolic compounds. In: Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology, pp. 1–49. Fraga CG., ed., JohnWiley & Sons, Hoboken, New Jersey.
   Google Scholar
• Jawaid, K., Crane, S. R., Nowers, J. L., Lacey, M. and Whitehead, S. A. (2010). Long-term genistein treatment of MCF-7 cells decreases acetylated histone 3 expression and alters growth responses to mitogens and histone deacetylase inhibitors. J. Steroid Biochem. Mol. Biol. 120(4):164–171.
   PubMed Web of Science ®Google Scholar
• Jiang, X., Patterson, N. M., Ling, Y., Xie, J., Helferich, W. G. and Shapiro, D. J. (2008). Low concentrations of the soy phytoestrogen genistein induce proteinase inhibitor 9 and block killing of breast cancer cells by immune cells. Endocrinology. 149:5366–5373.
   PubMed Web of Science ®Google Scholar
• Jin, Z. and MacDonald, R. S. (2002). Soy isoflavones increase latency of spontaneous mammary tumors in mice. J. Nutr. 132:3186–3190.
   PubMed Web of Science ®Google Scholar
• Ju, Y. H., Allred, C. D., Allred, K. F., Karko, K. L., Doerge, D. R. and Helferich, W. G. (2001). Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr. 131:2957–2962.
   PubMed Web of Science ®Google Scholar
• Ju, Y. H., Fultz, J., Allred, K. F., Doerge, D. R. and Helferich, W. G. (2006). Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis. 27:856–863.
   PubMed Web of Science ®Google Scholar
• Juan, H. X., Xie, M. and Diel, P. (2013). The phytoestrogen Genistein inhibits the anti-tumor activity of cisplatin in MCF-7 breast and HT29 colon cancer cells. Exp. Clin. Endocrinol. Diab. 121(3).
   Google Scholar
• Kano, M., Takayanagi, T., Harada, K., Sawada, S. and Ishikawa, F. (2006). Bioavailability of isoflavones after ingestion of soy beverages in healthy adults. J. Nutr. 136:2291–2296.
   PubMed Web of Science ®Google Scholar
• Karieb, S. and Fox, S. W. (2011). Phytoestrogens directly inhibit TNF-α-induced bone resorption in RAW264. 7 cells by suppressing c‐fos-induced NFATc1 expression. J. Cell. Biochem. 112:476–487.
   PubMed Web of Science ®Google Scholar
• Keinan-Boker, L., van Der Schouw, Y. T., Grobbee, D. E. and Peeters, P. H. (2004). Dietary phytoestrogens and breast cancer risk. Am. J. Clin. Nutr. 79:282–288.
   PubMed Web of Science ®Google Scholar
• Kenny, A. M., Mangano, K. M., Abourizk, R. H., Bruno, R. S., Anamani, D. E., Kleppinger, A., et al. (2009). Soy proteins and isoflavones affect bone mineral density in older women: A randomized controlled trial. Am. J. Clin. Nutr. 90:234–242.
   PubMed Web of Science ®Google Scholar
• Ketron, A. C., and Osheroff, N. (2014). Phytochemicals as anticancer and chemopreventive topoisomerase II poisons. Phytochem. Rev. 13(1):19–35.
   PubMed Web of Science ®Google Scholar
• Khan, S. A., Chatterton, R. T., Michel, N., Bryk, M, Lee, O., Ivancic, D., et al. (2012). Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial. Cancer Prev. Res. 5:309–319.
   PubMed Web of Science ®Google Scholar
• Khovidhunkit, W and Shoback, D. M. (1999). Clinical effects of raloxifene hydrochloride in women. Ann.Int. Med. 130:431.
   PubMed Web of Science ®Google Scholar
• Kilkkinen, A., Stumpf, K., Pietinen, P., Valsta, L. M., Tapanainen, H. and Adlercreutz, H. (2001). Determinants of serum enterolactone concentration. Am. J. Clin. Nutr. 73:1094–1100.
   PubMed Web of Science ®Google Scholar
• Kim, T.-H., Jung, J. W., Ha, B. G., Hong, J. M., Park, E. K., Kim, H.-J., et al. (2011). The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss. J. Nutr. Biochem. 22:8–15.
   PubMed Web of Science ®Google Scholar
• Kirkman, L. M., Lampe, J. W., Campbell, D. R., Martini, M. C. and Slavin, J. L. (1995). Urinary lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets. Nutr Cancer. 24:1–12.
   PubMed Web of Science ®Google Scholar
• Knowlden, J. M., Gee, J. M., Robertson, J. F., Ellis, I. O. and Nicholson, R. I. (2000). A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer. Int. J. Cancer. 89:209–212.
   PubMed Web of Science ®Google Scholar
• Kobayashi, S., Nagai, T., Konishi, Y., Tanabe, S., Morimoto, K. and Ogihara, T. (2012). Transport mechanisms of flavanone aglycones across Caco-2 cell monolayers and artificial PAMPA membranes. J. Pharm. Pharmacol. 64:52–60.
   PubMed Web of Science ®Google Scholar
• Korde, L. A., Wu, A. H., Fears, T., Nomura, A. M. Y, West, D. W., Kolonel, L. N., et al. (2009). Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol. Biomarkers Prev. 18:1050–1059.
   PubMed Web of Science ®Google Scholar
• Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology. 139:4252–4263.
   PubMed Web of Science ®Google Scholar
• Kurzer, M. (2008). Soy consumption for reduction of menopausal symptoms. Inflammopharmacology. 16:227–229.
   PubMedGoogle Scholar
• Labeling, F. (1999). Health claims; soy protein and coronary heart disease. Food Drug Admin. 21.
   Google Scholar
• Lamartiniere, C. A., Cotroneo, M. S., Fritz, W. A., Wang, J., Mentor-Marcel, R. and Elgavish, A. (2002). Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J.Nutr. 132:552S–558S.
   PubMed Web of Science ®Google Scholar
• Lambe, M., Wigertz, A., Holmqvist, M., Adolfsson, J., Bardage, C., Fornander, T., et al. (2010). Reductions in use of hormone replacement therapy: Effects on Swedish breast cancer incidence trends only seen after several years. Breast Cancer Res. Treat. 121:679–683.
   PubMed Web of Science ®Google Scholar
• Lampe, J. W., Karr, S. C., Hutchins, A. M. and Slavin, J. L. (1998). Urinary equol excretion with a soy challenge: Influence of habitual diet. In: Proceedings of the Society for Experimental Biology and Medicine, Society for Experimental Biology and Medicine, pp. 335–339. Royal Society of Medicine. New York, NY.
   Google Scholar
• Le Bail, J., Varnat, F., Nicolas, J. and Habrioux, G. (1998). Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett. 130:209–216.
   PubMed Web of Science ®Google Scholar
• Lee, R. J., Albanese, C., Stenger, R. J., Watanabe, G., Inghirami, G., Haines, G. K., et al. (1999). pp60v- src Induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways: A role for cAMP response element-binding protein and activating transcription factor-2 in pp60v-src signaling in breast cancer cells. J. Biol. Chem. 274:7341–7350.
   PubMed Web of Science ®Google Scholar
• Lee, S. A., Shu, X. O., Li, H., Yang, G., Cai, H., Wen, W., et al. (2009). Adolescent and adult soy food intake and breast cancer risk: Results from the Shanghai Women's Health Study. Am. J. Clin. Nutr. 89:1920–1926.
   PubMed Web of Science ®Google Scholar
• Levine, J. P. (2007). Effective strategies to identify postmenopausal women at risk for osteoporosis[J]. Geriatrics. 62(11):22–30.
   PubMed Web of Science ®Google Scholar
• Li, S.-H., Liu, X.-X., Bai, Y.-Y., Wang, X.-J., Sun, K., Chen, J.-Z., et al. (2010). Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials. Am. J. Clin. Nutr. 91:480–486.
   PubMed Web of Science ®Google Scholar
• Li, Y., Kong, D., Ahmad, A., et al. (2013). Antioxidant function of isoflavone and 3, 3′-diindolylmethane: are they important for cancer prevention and therapy?[J]. Antioxidants Redox Signaling. 19(2):139–150.
   PubMed Web of Science ®Google Scholar
• Li, Y.-Q., Xing, X.-H., Wang, H., Weng, X.-L., Yu, S.-B. and Dong, G.-Y. (2012). Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone. Acta Pharmacol. Sin. 33:66–74.
   PubMed Web of Science ®Google Scholar
• Liao, Mei-Hsiu, et al. (2014). Genistein induces oestrogen receptor-α gene expression in osteoblasts through the activation of mitogen-activated protein kinases/NF-κB/activator protein-1 and promotes cell mineralisation. Br. J. Nutr. 111.01:55–63.
   Web of Science ®Google Scholar
• Limer, J. L and Speirs, V. (2004). Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res. 6(3):119–127.
   PubMed Web of Science ®Google Scholar
• Lindahl, G., Saarinen, N., Abrahamsson, A. and Dabrosin, C. (2011). Tamoxifen, flaxseed, and the lignan enterolactone increase stroma-and cancer cell–derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer. Cancer Res. 71:51–60.
   PubMed Web of Science ®Google Scholar
• Linseisen, J., Piller, R., Hermann, S. and Chang-Claude, J. (2004). Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int. J. Cancer. 110:284–290.
   PubMed Web of Science ®Google Scholar
• Liu, B., Edgerton, S, Yang, X., Kim, A., Ordonez-Ercan, D., Mason, T, et al. (2005). Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Cancer Res. 65:879–886.
   PubMed Web of Science ®Google Scholar
• Liu, X. X., Li, S. H., Chen, J. Z., Sun, K., Wang, X. J., Wang, X. G., et al. (2012). Effect of soy isoflavones on blood pressure: A meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovas. Dis. 22:463–470.
   PubMed Web of Science ®Google Scholar
• Liu, Y and Hu, M. (2002). Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. Drug Metab. Dispos. 30:370–377.
   PubMed Web of Science ®Google Scholar
• Liu, Z.-M., Chen, Y.-M., Ho, S. C., Ho, Y. P. and Woo, J. (2010). Effects of soy protein and isoflavones on glycemic control and insulin sensitivity: A 6-MO double-blind, randomized, placebo-controlled trial in postmenopausal Chinese women with prediabetes or untreated early diabetes. Am. J. Clin. Nutr. 91:1394–1401.
   PubMed Web of Science ®Google Scholar
• Liu, Z.-M, Chen, Y.-M. and Ho, S. C. (2011). Effects of soy intake on glycemic control: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 93:1092–1101.
   PubMed Web of Science ®Google Scholar
• Lowcock, E. C., Cotterchio, M. and Boucher, B. A. (2013). Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk[J]. Cancer Causes Control. 24(4):813–816.
   PubMed Web of Science ®Google Scholar
• Lucki, N. C. and Sewer, M. B. (2011). Genistein stimulates MCF-7 breast cancer cell growth by inducing acid ceramidase (ASAH1) gene expression. J. Biol. Chem. 286:19399–19409.
   PubMed Web of Science ®Google Scholar
• Lydeking-Olsen, E., Jensen, J. E. B., Setchell, K. D. R., Damhus, M., and Jensen, T. H. (2002, March). Isoflavone-rich soymilk prevents bone loss in the lumbar spine of postmenopausal women: A two-year study. J. Nutr. 132(3):581S–581S. ( Amer. Inst. Nutrition, Rockville Pike, Bethesda, MD)
   Web of Science ®Google Scholar
• MacLennan, A., Lester, S. and Moore, V. (2001). Oral oestrogen replacement therapy versus placebo for hot flushes. Cochrane Database of Systematic Reviews, 55(1):295–296.
   Google Scholar
• Magee, P., Allsopp, P., Samaletdin, A. and Rowland, I. (2013). Daidzein, R-(+) equol and S-(−) equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the downregulation of matrix metalloproteinase-2. Eur. J. Nutr. 53(1):345–350.
   PubMedGoogle Scholar
• Maggiolini, M., Vivacqua, A., Fasanella, G., Recchia, A. G., Sisci, D., Pezzi, V., et al. (2004). The G Protein-coupled Receptor GPR30 mediates c-fos upregulation by 17β-estradiol and phytoestrogens in breast cancer cells. J. Biol. Chem. 279:27008–27016.
   PubMed Web of Science ®Google Scholar
• Mai, Z., Blackburn, G. L. and Zhou, J. R. (2007). Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells. Mol. Carcinog. 46:534–542.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., et al. (1995). The nuclear receptor superfamily: The second decade. Cell. 83:835–839.
   PubMed Web of Science ®Google Scholar
• Manna, S. K. (2012). Double-edged sword effect of biochanin to inhibit nuclear factor kappaB: Suppression of serine/threonine and tyrosine kinases. Biochem. Pharmacol. 83:1383–1392.
   PubMed Web of Science ®Google Scholar
• Marino, M., Pallottini, V. and Trentalance, A. (1998). Estrogens cause rapid activation of IP3-PKC-α signal transduction pathway in HEPG2 cells. Biochem. Biophys. Res. Commun. 245:254–258.
   PubMed Web of Science ®Google Scholar
• Markiewicz, L., Garey, J., Adlercreutz, H. and Gurpide, E. (1993). In vitro bioassays of non-steroidal phytoestrogens. J. Steroid Biochem. Mol. Biol. 45:399–405.
   PubMed Web of Science ®Google Scholar
• Maskarinec, G., Takata, Y., Franke, A. A., Williams, A. E. and Murphy, S. P. (2004). A 2-year soy intervention in premenopausal women does not change mammographic densities. J. Nutr. 134:3089–3094.
   PubMed Web of Science ®Google Scholar
• Maskarinec, G., Williams, A. and Carlin, L. (2003). Mammographic densities in a one-year isoflavone intervention. Eur. J. Cancer Prev. 12:165–169.
   PubMed Web of Science ®Google Scholar
• Mason, J. K., and Thompson, L. U. (2013). Flaxseed and its lignan and oil components: Can they play a role in reducing the risk of and improving the treatment of breast cancer? 1. App. Physiol. Nutr. Metab. 39(6):663–678.
   PubMed Web of Science ®Google Scholar
• Matvienko, O. A., Alekel, D. L., Genschel, U., Ritland, L., Van Loan, M. D. and Koehler, K. J. (2010). Appetitive hormones, but not isoflavone tablets, influence overall and central adiposity in healthy postmenopausal women. Menopause (New York) 17:594.
   PubMedGoogle Scholar
• Mazur, W., Uehara, M., Wähälä, K. and Adlercreutz, H. (2000). Phyto-oestrogen content of berries, and plasma concentrationsand urinary excretion of enterolactone after asingle strawberry-meal in human subjects. Brit. J. Nutr. 83:381–387.
   PubMed Web of Science ®Google Scholar
• McMichael-Phillips, D. F., Harding, C., Morton, M., Roberts, S. A., Howell, A., Potten, C. S., et al. (1998). Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am. J. Clin. Nutr. 68:1431S–1435S.
   PubMed Web of Science ®Google Scholar
• Migliaccio, A., Di Domenico, M., Castoria, G., De Falco, A., Bontempo, P., Nola, E., et al. (1996). Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15:1292.
   PubMed Web of Science ®Google Scholar
• Molzberger, A. F., Vollmer, G., Hertrampf, T., Möller, F. J., Kulling, S. and Diel, P. (2012). In utero and postnatal exposure to isoflavones results in a reduced responsivity of the mammary gland towards estradiol. Mol. Nutr. Food Res. 56:399–409.
   PubMed Web of Science ®Google Scholar
• Morand, C., Crespy, V., Manach, C., Besson, C, Demigné, C. and Rémésy, C. (1998). Plasma metabolites of quercetin and their antioxidant properties. Am. J. Physiol. Regul. Integr. Comp. Physiol. 275:R212–R219.
   PubMed Web of Science ®Google Scholar
• Mousavi, Y. and Adlercreutz, H. (1992). Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. J. Steroid Biochem. Mol. Biol. 41:615–619.
   PubMed Web of Science ®Google Scholar
• Muir, A., Westcott, N., Ballantyne, K. and Northrup, S. (2000). Flax lignans – Recent developments in the analysis of lignans in plant and animal tissues. Proc. Flax Inst. 58:23–32.
   Google Scholar
• Muir, A., Westcott, N. and Prasad, K. (1997). Extraction, purification and animal model testing of an anti-atherosclerotic lignan secoisolariciresinol diglucoside from flaxseed (Linum usitatissimum). In: II WOCMAP Congress on Medicinal and Aromatic Plants, Part 2: Pharmacognosy, Pharmacology, Phytomedicine, Toxicology, Vol. 501, pp. 245–248.
   Google Scholar
• Murota, K and Terao, J. (2003). Antioxidative flavonoid quercetin: Implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys. 417:12–17.
   PubMed Web of Science ®Google Scholar
• Muthyala, R. S., Ju, Y. H., Sheng, S., Williams, L. D., Doerge, D. R., Katzenellenbogen, B. S., et al. (2004). Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R-and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorgan. Med. Chem. 12:1559.
   PubMed Web of Science ®Google Scholar
• Nagata, C., Takatsuka, N., Kurisu, Y. and Shimizu, H. (1998). Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J. Nutr. 128:209–213.
   PubMed Web of Science ®Google Scholar
• Naragoni, S., Sankella, S., Harris, K. and Gray, W. G. (2009). Phytoestrogens regulate mRNA and protein levels of guanine nucleotide-binding protein, beta-1 subunit (GNB1) in MCF-7 cells. J. Cell. Physiol. 219:584–594.
   PubMed Web of Science ®Google Scholar
• Nesbitt, P. D., Lam, Y. and Thompson, L. U. (1999). Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am. J. Clin. Nutr. 69:549–555.
   PubMed Web of Science ®Google Scholar
• Nielsen, T. S., Purup, S., Wärri, A., Godschalk, R. W. and Hilakivi-Clarke, L. (2011). Effects of maternal exposure to cow's milk high or low in isoflavones on carcinogen-induced mammary tumorigenesis among rat offspring. Cancer Prev. Res. 4:694–701.
   PubMed Web of Science ®Google Scholar
• Nishio, K., Niwa, Y., Toyoshima, H., Tamakoshi, K., Kondo, T, Yatsuya, H., et al. (2007). Consumption of soy foods and the risk of breast cancer: Findings from the Japan collaborative cohort (JACC) study. Cancer Causes Control. 18:801–808.
   PubMed Web of Science ®Google Scholar
• Ohtomo, T., Uehara, M., Peñalvo, J. L., Adlercreutz, H., Katsumata, S.-I. and Suzuki, K. (2008). Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures. Eur. J. Nutr. 47:273–279.
   PubMed Web of Science ®Google Scholar
• Ono, M., Koga, T., Ueo, H. and Nakano, S. (2012). Effects of dietary genistein on hormone-dependent rat mammary carcinogenesis induced by ethyl methanesulphonate. Nutr. Cancer. 64:1204–1210.
   PubMed Web of Science ®Google Scholar
• Padilla-Banks, E., Jefferson, W. N. and Newbold, R. R. (2006). Neonatal exposure to the phytoestrogen genistein alters mammary gland growth and developmental programming of hormone receptor levels. Endocrinology. 147:4871–4882.
   PubMed Web of Science ®Google Scholar
• Paech, K., Webb, P., Kuiper, G. G., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., et al. (1997). Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science. 277:1508–1510.
   PubMed Web of Science ®Google Scholar
• Palacios, V. G., Robinson, L. J., Borysenko, C. W., Lehmann, T., Kalla, S. E. and Blair, H. C. (2005). Negative regulation of RANKL-induced osteoclastic differentiation in RAW264. 7 cells by estrogen and phytoestrogens. J. Biol. Chem. 280:13720–13727.
   PubMed Web of Science ®Google Scholar
• Pavese, J., Farmer, R. and Bergan, R. (2010). Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metast. Rev. 29:465–482.
   PubMed Web of Science ®Google Scholar
• Pei, R. J., Sato, M., Yuri, T., Danbara, N., Nikaido, Y. and Tsubura, A. (2003). Effect of prenatal and prepubertal genistein exposure on N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague–Dawley rats. In vivo (Athens Greece) 17:349–357.
   PubMed Web of Science ®Google Scholar
• Peng, J.-H., Zhu, J.-D., Mi, M.-T., Li, F.-J., Cai, L., Dong, J.-Z., et al. (2010). Prepubertal genistein exposure affects erbB2/Akt signal and reduces rat mammary tumorigenesis. Eur. J. Cancer Prev. 19:110–119.
   PubMed Web of Science ®Google Scholar
• Petrakis, N. L., Barnes, S., King, E. B., Lowenstein, J., Wiencke, J., Lee, M. M., et al. (1996). Stimulatory influence of soy protein isolate on breast secretion in pre-and postmenopausal women. Cancer Epidemiol. Biom. Prev. 5:785–794.
   PubMed Web of Science ®Google Scholar
• Pietinen, P., Stumpf, K., Männistö, S., Kataja, V., Uusitupa, M. and Adlercreutz, H. (2001). Serum enterolactone and risk of breast cancer a case-control study in eastern Finland. Cancer Epidem. Biom. Prev. 10:339–344.
   PubMed Web of Science ®Google Scholar
• Pillow, P. C., Duphorne, C. M., Chang, S., Contois, J. H., Strom, S. S., Spitz, M. R., et al. (1999). Development of a database for assessing dietary phytoestrogen intake. Nutrition & Cancer. 33(1):3–19.
   Google Scholar
• Pipe, E. A., Gobert, C. P., Capes, S. E., Darlington, G. A., Lampe, J. W. and Duncan, A. M. (2009). Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratios in adults with type 2 diabetes. J. Nutr. 139:1700–1706.
   PubMed Web of Science ®Google Scholar
• Piskula, M. K. and Terao, J. (1998). Accumulation of (−)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J. Nutr. 128:1172–1178.
   PubMed Web of Science ®Google Scholar
• Piskula, M. K., Yamakoshi, J. and Iwai, Y. (1999). Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Lett. 447:287–291.
   PubMed Web of Science ®Google Scholar
• Quella, S. K., Loprinzi, C. L., Barton, D. L., Knost, J. A., Sloan, J. A., LaVasseur, B. I., et al. (2000). Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J. Clin. Oncol. 18:1068–1068.
   PubMed Web of Science ®Google Scholar
• Riesco, E., Aubertin-Leheudre, M., Maltais, M. L., Audet, M. and Dionne, I. J. (2010). Synergic effect of phytoestrogens and exercise training on cardiovascular risk profile in exercise-responder postmenopausal women: A pilot study. Menopause. 17:1035–1039
   PubMed Web of Science ®Google Scholar
• Riggs, B. L. and Hartmann, L. C. (2003). Selective estrogen-receptor modulators – Mechanisms of action and application to clinical practice. New Engl. J. Med. 348:618–629.
   PubMed Web of Science ®Google Scholar
• Ronis, M. J., Chen, Y., Badeaux, J. and Badger, T. M. (2009). Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J.Nutr. 139:1431–1438.
   PubMed Web of Science ®Google Scholar
• Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M., et al. (2002). Writing group for the women's health initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. JAMA. 288:321–333.
   PubMed Web of Science ®Google Scholar
• Rowland, I., Faughnan, M. and Hoey, L. (2003). Bioavailability of phyto-oestrogens[J]. Br. J. Nutr. 89(S1):S45–S58.
   PubMedGoogle Scholar
• Rüfer, C. E., Bub, A., Möseneder, J., Winterhalter, P., Stürtz, M. and Kulling, S. E. (2008). Pharmacokinetics of the soybean isoflavone daidzein in its aglycone and glucoside form: A randomized, double-blind, crossover study. Am. J. Clin. Nutr. 87:1314–1323.
   PubMed Web of Science ®Google Scholar
• Saad, H. E. S, Meduri, G., Phrakonkham, P., Bergès, R., Vacher, S, Djallali, M., et al. (2011). Abnormal peripubertal development of the rat mammary gland following exposure in utero and during lactation to a mixture of genistein and the food contaminant vinclozolin. Reprod. Toxicol. 32:15–25.
   PubMed Web of Science ®Google Scholar
• Saarinen, N. M., Abrahamsson, A. and Dabrosin, C. (2010). Estrogen-induced angiogenic factors derived from stromal and cancer cells are differently regulated by enterolactone and genistein in human breast cancer in vivo. Int. J. Cancer. 127:737–745.
   PubMed Web of Science ®Google Scholar
• Sacks, F. M., Lichtenstein, A., Van Horn, L., Harris, W., Kris-Etherton, P. and Winston, M. (2006). Soy protein, isoflavones, and cardiovascular health. Circulation. 113:1034–1044.
   PubMed Web of Science ®Google Scholar
• Safe, S. (2001). Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitam. Horm. 62:231–252.
   PubMed Web of Science ®Google Scholar
• Sakamoto, T., Horiguchi, H., Oguma, E. and Kayama, F. (2010). Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells. J. Nutr. Biochem. 21:856–864.
   PubMed Web of Science ®Google Scholar
• Schairer, C., Lubin, J., Troisi, R., Sturgeon, S., Brinton, L. and Hoover, R. (2000). Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 283:485–491.
   PubMed Web of Science ®Google Scholar
• Schmitt, E., Dekant, W. and Stopper, H. (2001). Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues. Toxicol. in Vitro. 15:433–439.
   PubMed Web of Science ®Google Scholar
• Schwanck, B., Behrendt, M., Naim, H. and Blaschek, W. (2011). Deglycosylation of individual flavonoids and flavonoid containing plant extracts by purified human intestinal lactase-phlorizin hydrolase (LPH). Planta Med. 77:PA22.
   Google Scholar
• Seo, H.-S., DeNardo, D. G., Jacquot, Y., Laïos, I., Vidal, D. S., Zambrana, C. R., et al. (2006). Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res. Treat. 99:121–134.
   PubMed Web of Science ®Google Scholar
• Seo, H.-S., Ju, J.-H., Jang, K. and Shin, I. (2011). Induction of apoptotic cell death by phytoestrogens by upregulating the levels of phospho-p53 and p21 in normal and malignant estrogen receptor α-negative breast cells. Nutr. Res. 31:139–146.
   PubMed Web of Science ®Google Scholar
• Setchell, K. D. (2001). Soy isoflavones – Benefits and risks from nature's selective estrogen receptor modulators (SERMs). J. Am. Coll. Nutr. 20:354S–362S.
   PubMed Web of Science ®Google Scholar
• Setchell, K. D., Brown, N. M., Desai, P., Zimmer-Nechemias, L., Wolfe, B. E., Brashear, W. T., et al. (2001). Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr. 131:1362S–1375S.
   PubMed Web of Science ®Google Scholar
• Setchell, K. D., Brown, N. M., Desai, P. B., Zimmer-Nechimias, L., Wolfe, B, Jakate, A. S., et al. (2003). Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J. Nutr. 133:1027–1035.
   PubMed Web of Science ®Google Scholar
• Setchell, K. D., Brown, N. M. and Lydeking-Olsen, E. (2002). The clinical importance of the metabolite equol – A clue to the effectiveness of soy and its isoflavones. J. Nutr. 132:3577–3584.
   PubMed Web of Science ®Google Scholar
• Setchell, K. D., Brown, N. M., Zimmer-Nechemias, L., Brashear, W. T., Wolfe, B. E., Kirschner, A. S., et al. (2002). Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am. J. Clin. Nutr. 76:447–453.
   PubMed Web of Science ®Google Scholar
• Shang, Y and Brown, M. (2002). Molecular determinants for the tissue specificity of SERMs. Science. 295:2465–2468.
   PubMed Web of Science ®Google Scholar
• Sheu, S. Y., Tsai, C. C. and Sun, J. S. (2012). Stimulatory effect of puerarin on bone formation through co-activation of nitric oxide and bone morphogenetic protein-2/mitogen-activated protein kinases pathways in mice[J]. Chin. Med. J. 125(20):3646–3653.
   PubMed Web of Science ®Google Scholar
• Shu, X. Z. Y. C. H., et al. (2009). Soy food intake and breast cancer survival. JAMA. 302:2437–2443.
   PubMed Web of Science ®Google Scholar
• Shu, X. O., Jin, F., Dai, Q., Wen, W., Potter, J. D., Kushi, L. H., et al. (2001). Soy food intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol. Biomarkers Prev. 10:483–488.
   PubMed Web of Science ®Google Scholar
• Simbalista, R. L., Sauerbronn, A. V., Aldrighi, J. M. and Arêas, J. A. (2010). Consumption of a flaxseed-rich food is not more effective than a placebo in alleviating the climacteric symptoms of postmenopausal women. J. of Nutr. 140:293–297.
   PubMed Web of Science ®Google Scholar
• Sirtori, C. R., Arnoldi, A. and Johnson, S. K. (2005). Phytoestrogens: End of a tale? Ann. Med. 37:423–438.
   PubMed Web of Science ®Google Scholar
• Sirtori, C. R. (2001). Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Safety. 24:665–682.
   PubMed Web of Science ®Google Scholar
• Stalmach, A., Steiling, H. and Williamson, G., et al. (2010). Bioavailability of chlorogenic acids following acute ingestion of coffee by humans with an ileostomy[J]. Arch. Biochem. Biophys. 501(1):98–105.
   PubMedGoogle Scholar
• Takumi, H., Mukai, R. and Ishiduka, S. (2011). Tissue distribution of hesperetin in rats after a dietary intake[J]. Biosci. Biotechnol. Biochem. 75(8):1608–1610.
   PubMed Web of Science ®Google Scholar
• Tew, B. Y., Xu, X., Wang, H. J., Murphy, P. A. and Hendrich, S. (1996). A diet high in wheat fiber decreases the bioavailability of soybean isoflavones in a single meal fed to women. J. Nutr. 126:871–877.
   PubMed Web of Science ®Google Scholar
• Tham, D. M., Gardner, C. D. and Haskell, W. L. (1998). Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 83:2223–2235.
   PubMed Web of Science ®Google Scholar
• Thanos, J., Cotterchio, M., Boucher, B. A., Kreiger, N. and Thompson, L. U. (2006). Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Contr. 17:1253–1261.
   PubMed Web of Science ®Google Scholar
• This, P., De La Rochefordi, A., Clough, K., Fourquet, A. and Magdelenat, H. (2001). Phytoestrogens after breast cancer. Endocr. Relat. Cancer. 8:129–134.
   PubMed Web of Science ®Google Scholar
• Thompson, L. U., Chen, J. M., Li, T., Strasser-Weippl, K. and Goss, P. E. (2005). Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin. Cancer Res. 11:3828–3835.
   PubMed Web of Science ®Google Scholar
• Thompson, L. U. (1999). Role of lignans in carcinogenesis. In: Phytochemicals in Human Health Protection, Nutrition, and Plant Defense, pp. 51–65. Romeo J., ed., Springer, New York, NY.
   Google Scholar
• Tophkhane, C., Shihe, Y., Bales, W., Archer, L., Osunkoya, A., Thor, A. D., et al. (2007). Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms. Int. J. Oncol. 31:867–874.
   PubMed Web of Science ®Google Scholar
• Touré, A and Xueming, X. (2010). Flaxseed lignans: Source, biosynthesis, metabolism, antioxidant activity, bioactive components, and health benefits. Compr. Rev. Food Sci. Food Saf. 9:261–269.
   PubMed Web of Science ®Google Scholar
• Tovar, A. R., Murguía, F, Cruz, C., Hernández-Pando, R., Aguilar-Salinas, C. A., Pedraza-Chaverri, J., et al. (2002). A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J. Nutr. 132:2562–2569.
   PubMed Web of Science ®Google Scholar
• Travis, R. C., Allen, N. E., Appleby, P. N., Spencer, E. A., Roddam, A. W. and Key, T. J. (2008). A prospective study of vegetarianism and isoflavone intake in relation to breast cancer risk in British women. Int. J. Cancer. 122:705–710.
   PubMed Web of Science ®Google Scholar
• Trock, B. J., Hilakivi-Clarke, L. and Clarke, R. (2006). Meta-analysis of soy intake and breast cancer risk. J. Natl. Cancer Inst. 98:459–471.
   PubMed Web of Science ®Google Scholar
• Ueda, M., Niho, N., Imai, T., Shibutani, M., Mitsumori, K., Matsui, T., et al. (2003). Lack of significant effects of genistein on the progression of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in ovariectomized Sprague–Dawley rats. Nutr. Cancer. 47:141–147.
   PubMed Web of Science ®Google Scholar
• Valaciiovicova, T., Slivova, V., Bergman, H., Shuherk, J. and Sliva, D (2004). Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-κB/AP-1-dependent and-independent pathways. Int. J. Oncol. 25:1389–1395.
   PubMed Web of Science ®Google Scholar
• van de Weijer, P. H. M. and Barentsen, R. (2002). Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo[J]. Maturitas. 42(3):187–193.
   PubMed Web of Science ®Google Scholar
• van Duursen, M. B., Nijmeijer, S., de Morree, E., de Jong, P. C. and van den Berg, M. (2011). Genistein induces breast cancer-associated aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model. Toxicology. 289:67–73.
   PubMed Web of Science ®Google Scholar
• Vanden Berghe, W., De Naeyer, A., Dijsselbloem, N., David, J.-P., De Keukeleire, D. and Haegeman, G. (2011). Attenuation of ERK/RSK2-Driven NFB gene expression and cancer cell proliferation by Kurarinone, a Lavandulyl flavanone isolated from Sophora flavescens AIT. roots. Endocr. Metab. Immun. Dis. Drug Targets 11:247–261.
   PubMedGoogle Scholar
• Vantyghem, S. A., Wilson, S. M., Postenka, C. O., Al-Katib, W., Tuck, A. B. and Chambers, A. F. (2005). Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model. Cancer Res. 65:3396–3403.
   PubMed Web of Science ®Google Scholar
• Verheus, M., Van Gils, C. H., Keinan-Boker, L., Grace, P. B., Bingham, S. A. and Peeters, P. H. (2007). Plasma phytoestrogens and subsequent breast cancer risk. J. Clin. Oncol. 25:648–655.
   PubMed Web of Science ®Google Scholar
• Verheus, M., van Gils, C. H., Kreijkamp-Kaspers, S., Kok, L., Peeters, P. H. M, Grobbee, D. E., et al. (2008). Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 17:2632–2638.
   PubMed Web of Science ®Google Scholar
• Verkasalo, P. K., Appleby, P. N., Allen, N. E., Davey, G., Adlercreutz, H. and Key, T. J. (2001). Soya intake and plasma concentrations of daidzein and genistein: validity of dietary assessment among eighty British women (Oxford arm of the European Prospective Investigation into Cancer and Nutrition). Br. J. Nutr. 86:415–421.
   PubMed Web of Science ®Google Scholar
• Walker, H., Dean, T., Sanders, T., Jackson, G., Ritter, J. and Chowienczyk, P. (2001). The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17β-estradiol. Circulation 103:258–262.
   PubMed Web of Science ®Google Scholar
• Wang, C. and Kurzer, M. S. (1997). Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutrition & Cancer, 28(3):236–247.
   Google Scholar
• Wang, L.-Q. (2002). Mammalian phytoestrogens: Enterodiol and enterolactone. J. Chromatogr. B. 777:289–309.
   PubMed Web of Science ®Google Scholar
• Wang, S. F., Jiang, Q., Ye, Y. H., Li, Y. and Tan, R. X. (2005). Genistein derivatives as selective estrogen receptor modulators: Sonochemical synthesis and in vivo anti-osteoporotic action. Bioorgan. Med. Chem. 13:4880–4890.
   PubMed Web of Science ®Google Scholar
• Wangen, K. E., Duncan, A. M., Merz-Demlow, B. E., Xu, X., Marcus, R., Phipps, W. R., et al. (2000). Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J. Clin. Endocrinol. Metab. 85:3043–3048.
   PubMed Web of Science ®Google Scholar
• Ward, H. A., Kuhnle, G. G. C., Mulligan, A. A., Lentjes, M. A. H., Luben, R. N. and Khaw, K. T. (2010). Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition – Norfolk in relation to phytoestrogen intake derived from an improved database. Am. J. Clin. Nutr. 91:440–448.
   PubMed Web of Science ®Google Scholar
• Warri, A., Saarinen, N., Makela, S. and Hilakivi-Clarke, L. (2008). The role of early life genistein exposures in modifying breast cancer risk. Br. J. Cancer. 98:1485–1493.
   PubMed Web of Science ®Google Scholar
• Watson, K. L., Stalker, L. and Jones, R. A. (2015). High levels of dietary soy decrease mammary tumor latency and increase incidence in MTB-IGFIR transgenic mice[J]. BMC Cancer. 15(1):37.
   PubMed Web of Science ®Google Scholar
• Weggemans, R. and Trautwein, E. (2003). Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: A meta-analysis. Eur. J. Clin. Nutr. 57:940–946.
   PubMed Web of Science ®Google Scholar
• Wu, A. H., Wan, P., Hankin, J., Tseng, C. C., Yu, M. C. and Pike, M. C. (2002). Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis. 23:1491–1496.
   PubMed Web of Science ®Google Scholar
• Wu, A. H., Ziegler, R. G., Horn-Ross, P. L., Nomura, A., West, D. W., Kolonel, L. N., et al. (1996). Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol. Biomarkers Prev. 5:901–906.
   PubMed Web of Science ®Google Scholar
• Wu, J., Oka, J., Higuchi, M., Tabata, I., Toda, T., Fujioka, M., et al. (2006). Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial. Metab. Clin. Exp. 55:423–433.
   PubMed Web of Science ®Google Scholar
• Wu, J., Wang, X. X., Takasaki, M., Ohta, A., Higuchi, M. and Ishimi, Y. (2001). Cooperative effects of exercise training and genistein administration on bone mass in ovariectomized mice. J. Bone Miner. Res. 16:1829–1836.
   PubMed Web of Science ®Google Scholar
• Yeung, J., and Yu, T. F. (2003). Effects of isoflavones (soy phyto-estrogens) on serum lipids: A meta-analysis of randomized controlled trials. Nutr. J. 2(1):15.
   PubMedGoogle Scholar
• Yin, J., Han, N., Liu, Z., Song, S. and Kadota, S. (2010). The in vitro antiosteoporotic activity of some glycosides in Dioscorea spongiosa. Biol. Pharm. Bull. 33:316–320.
   PubMed Web of Science ®Google Scholar
• Yuan, J., Wang, Q., Ross, R., Henderson, B. and Yu, M. (1995). Diet and breast cancer in Shanghai and Tianjin, China. Br. J. Cancer. 71:1353.
   PubMed Web of Science ®Google Scholar
• Yuan, J. P., Wang, J. H. and Liu, X. (2007). Metabolism of dietary soy isoflavones to equol by human intestinal microflora – Implications for health. Mol. Nutr. Food Res. 51:765–781.
   PubMed Web of Science ®Google Scholar
• Zhan, S. and Ho, S. C. (2005). Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am. J. Clin. Nutr. 81:397–408.
   PubMed Web of Science ®Google Scholar
• Zhang, G. P., Han, D., Liu, G., et al. (2012). Effects of soy isoflavone and endogenous oestrogen on breast cancer in MMTV-erbB2 transgenic mice[J]. J. Int. Med. Res. 40(6):2073–2082.
   PubMed Web of Science ®Google Scholar
• Zhang, X., Shu, X. O., Gao, Y.-T., Yang, G., Li, Q., Li, H, et al. (2003). Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J. Nutr. 133:2874–2878.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.-B., Chen, W.-H., Guo, J.-J., Fu, Z.-H., Yi, C, Zhang, M., et al. (2013). Soy isoflavone supplementation could reduce body weight and improve glucose metabolism in non-Asian postmenopausal women – A meta-analysis. Nutrition. 29:8–14.
   PubMed Web of Science ®Google Scholar
• Zhou, S., Hu, Y., Zhang, B, Teng, Z, Gan, H, Yang, Z, et al. (2008). Dose-dependent absorption, metabolism, and excretion of genistein in rats. J. Agr. Food Chem. 56:8354–8359.
   PubMed Web of Science ®Google Scholar
• Zhuo, X.-G., Melby, M. K. and Watanabe, S. (2004). Soy isoflavone intake lowers serum LDL cholesterol: A meta-analysis of 8 randomized controlled trials in humans. J. Nutr. 134:2395–2400.
   PubMed Web of Science ®Google Scholar